Formulary decision-making in public hospitals and private clinics in France: the role of pharmacoeconomic information

Hans-Martin Späth, Marie Charavel, Magali Morelle () and Marie-Odile Carrère
Additional contact information
Hans-Martin Späth: UCBL ISPB - Université Claude Bernard Lyon 1 - Institut des Sciences Pharmaceutiques et Biologiques - UCBL - Université Claude Bernard Lyon 1 - Université de Lyon
Marie Charavel: UPMF - Université Pierre Mendès France - Grenoble 2
Magali Morelle: GATE - Groupe d'analyse et de théorie économique - UL2 - Université Lumière - Lyon 2 - ENS LSH - Ecole Normale Supérieure Lettres et Sciences Humaines - CNRS - Centre National de la Recherche Scientifique
Marie-Odile Carrère: GATE - Groupe d'analyse et de théorie économique - UL2 - Université Lumière - Lyon 2 - ENS LSH - Ecole Normale Supérieure Lettres et Sciences Humaines - CNRS - Centre National de la Recherche Scientifique

Post-Print from HAL

Keywords: Health economy; Evaluation; Economic aspect; Chemist; Hospital environment; Hospital pharmacy; Decision aid; Drug; Hospital; Rhône Alpes; Survey (search for similar items in EconPapers)
Date: 2005
References: Add references at CitEc
Citations:

Published in Journal d'Economie Médicale, 2005, 7-8, pp. 347-354

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:halshs-00365954

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().